Evommune, Inc. (EVMN)
25.09
-0.52
(-2.03%)
USD |
NYSE |
Mar 03, 13:12
Evommune EPS Diluted (Quarterly) : -0.3957 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Moderna, Inc. | -2.107 |
| BillionToOne, Inc. | 0.0329 |
| Nektar Therapeutics | -1.875 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.48M |
| Revenue (Quarterly) | 10.00M |
| Total Expenses (Quarterly) | 22.48M |
| Enterprise Value | 989.04M |
| Gross Profit Margin (Quarterly) | 96.89% |
| Profit Margin (Quarterly) | -124.8% |
| Earnings Yield | -7.32% |
| Normalized Earnings Yield | -8.144 |